MD Anderson Cancer Center/University of Texas MD Anderson is a clinical research site located in Houston, Texas, United States 77030-4009.
Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
MD Anderson Cancer Center/University of Texas MD Anderson has participated in 2 clinical trials.
Therapeutic areas: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer, Myelodysplastic Syndromes.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Houston
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MD Anderson Cancer Center/University of Texas MD Anderson has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MD Anderson Cancer Center/University of Texas MD Anderson has 2 clinical trials on record. Their work covers Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer, Myelodysplastic Syndromes.
MD Anderson Cancer Center/University of Texas MD Anderson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.